Cargando…
Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress
Antiretroviral therapy (ART) restricts human immunodeficiency virus type one (HIV-1) replication and by so doing, improves the quality and longevity of life for infected people. Nonetheless, treatment can also lead to adverse clinical outcomes such as drug resistance and systemic adverse events. Bot...
Autores principales: | Montenegro-Burke, J. Rafael, Woldstad, Christopher J., Fang, Mingliang, Bade, Aditya N., McMillan, JoEllyn, Edagwa, Benson, Boska, Michael D., Gendelman, Howard E., Siuzdak, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403019/ https://www.ncbi.nlm.nih.gov/pubmed/30069830 http://dx.doi.org/10.1007/s12035-018-1273-8 |
Ejemplares similares
-
ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018) -
Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018) -
Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
por: Martinez-Skinner, Andrea L., et al.
Publicado: (2015) -
Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
por: Bade, Aditya N., et al.
Publicado: (2021) -
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim, Ibrahim M, et al.
Publicado: (2019)